Modified hemoglobin solution, with desired pharmacological properties, does not activate nuclear transcription factor NF-kappa B in human vascular endothelial cells

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology

Volumn 25, Issue 1-2, 1997, Pages 193-210

  Simoni, Jan ^a   Simoni, Grace ^a   Lox, Charles D ^a   Prien, Samuel D ^a   Shires, G Tom ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINETRIPHOSPHATE; AGENTS; ANIMAL CELL CULTURE; BLOOD VESSELS; CHEMICAL MODIFICATION; GENES; HEMOGLOBIN; HYDROGEN PEROXIDE; LIPIDS; OXIDATION;

ENDOTHELIUM; GLUTATHIONE; NUCLEAR TRANSCRIPTION FACTOR; NUCLEAR TRANSLOCATION; OXIDATIVE STRESS;

BLOOD SUBSTITUTES;

ADENOSINE; ADENOSINE TRIPHOSPHATE; BLOOD SUBSTITUTE; ENDOTOXIN; GLASS; GLUTARALDEHYDE; GLUTATHIONE; HEMOGLOBIN; HEMOGLOBIN DERIVATIVE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; PEROXIDASE; TUMOR NECROSIS FACTOR;

ARTICLE; AUTOOXIDATION; CATTLE; CELL CULTURE; CHEMICAL MODIFICATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE INDUCTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INFLAMMATION; LIPID PEROXIDATION; OXIDATIVE STRESS; POLYMERIZATION; VASCULAR ENDOTHELIUM;

EID: 0030902607     PISSN: 10731199     EISSN: None     Source Type: Journal    
DOI: 10.3109/10731199709118910     Document Type: Article

References (72)

1. Chang TMS: Past, present and future perspectives on the 40th anniversary of hemoglobin based red blood cell substitutes. Artif Cells Blood Substit Immobil Biotechnol 24(4):ix-xxiv(1996).
2. Winslow RM: Blood substitutes - a moving target. Nature Med 1(11):1212-15(1995).
3. Marwick C: More than a trickle of interest in blood substitutes. JAMA 271:895(1994).
4. Hess JR, Macdonald VW, Gomez CS, Coppes V: Increased vascular resistance with hemoglobin-based oxygen carriers. Artif Cells Blood Substit Immobil Biotechnol 22:361-72(1994).
5. Winslow RM: Hemoglobin-Based Red Cell Substitutes, Baltimore, The John Hopkins University Press, 1992.
6. Simoni J, Feola M, Canizaro PC: Generation of free oxygen radicals and toxicity of hemoglobin solutions. Biomater Artif Cells Artif Organs 18:189-202(1990).
7. Alayash AI: Hemoglobin-based blood substitutes: potential free radical toxicity. Free Rad Biol Med 16:137-8(1994).
8. Simoni J, Feola M, Tran R, Buckner M, Canizaro PC: Biocompatibility of hemoglobin solution. II. the inflammatory reaction of human monocytes and mouse peritoneal macrophages. Artif Organs 14:98-109(1990).
9. Simoni J, Simoni G, Lox CD, McGunegle DE, Feola M: Cytokines and PAF release from human monocytes and macrophages: effect of hemoglobin and contaminants. Artif Cells Blood Substit Immobil Biotechnol 22:525-34(1994).
10. McFaul SJ, Bowman PD, Villa VM, Gutierrez-Ibanez MJ, Johnson M, Smith D: Hemoglobin stimulates mononuclear leukocytes to release interleukin-8 and tumor necrosis factor alpha. Blood 84:3175-81(1994).
11. Smith DJ, Winslow RM: Effects of extraerythrocytic hemoglobin and its components on mononuclear cell procoagulant activity. J Lab Clin Med 119:176-82(1992).
12. Simoni J, Simoni G, Lox CD, Feola M: Reaction of human endothelial cells to bovine hemoglobin solution and tumor necrosis factor. Artif Cells Blood Substit Immobil Biotechnol 22:777-87(1994).
13. Simoni J, Simoni G, Lox CD, Prien SD, Shires GT: Evidence for the direct inhibition of endothelin-1 secretion by hemoglobin in human endothelial cells. ASAIO Journal 31:M641-51(1995).
14. Mottertini R, Foresti R, Vandegriff K, Intaglietta M, Winslow RM: Oxidative-stress response in vascular endothelial cells exposed to acellular hemoglobin solutions. Am J Physiol 269:H648-55(1995).
15. Alayash AI: Effects of intra- and intermolecular crosslinking on the free radical reactions of bovine hemoglobins. Free Rod Biol Med 18:295-301(1995).
16. Alayash AI, Fratantoni JC, Bonaventura C, Bonaventura J, Bucci E: Consequences of chemical modification on the free radical reactions of human hemoglobin. Arch Biochem Biophys 298:114-20(1992).
17. Cashon RE, Alayash AI: Reaction of human hemoglobin HbAo and two cross-linked derivatives with hydrogen peroxide: differential behavior of the ferryl intermediate. Arch Biochem Biophys 316:461-69(1995).
18. Simoni J, Simoni G, Lox CD, Prien SD, Tran R, Shires GT: Immunohistochemical evaluation of adhesion molecules and von Willebrand factor expression in human coronary artery endothelial cells incubated with different hemoglobin solutions. Artif Cells Blood Substit Immobil Biotechnol 24:426(1996).
19. Baeuerle PA, Baltimore PA: Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor. Cell 53:211-17(1988).
20. Grimm S, Baeuerle PA: The inducible transcription factor NF-kappa B: structure-function relationship of its protein subunits. Biochem J 290:297-308(1993).
21. Collins T: Endothelial nuclear factor-kappa B and the initiation of the artheriosclerotic lesion. Lab Invest 68:499-508(1993).
22. Parry GC, Mackman N: A set of inducible genes expressed by activated human monocytic and endothelial cells contain kappa B-like sites that specifically bind c-rel-p65 heterodimers. J Biol Chem 269:20823-5(1994).
23. Thanos D, Maniatis T: NF-kappa B: Lesson in family values. Cell 80:529-32(1995).
24. Siebenlist U, Franzoso G, Brown K: Structure, regulation and function of NF-kappa B. Annu. Rev Cell Biol 10:405-55(1994).
25. Schreck R, Albermann K, Baeuerle PA: Nuclear factor kappa B: an oxidative stress responsive transcription factor of eukaryotic cells. Free Rad Res Commun 17:221-37(1992).
26. Toledano MB, Leonard WJ: Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci USA 88:4328-32(1991).
27. Andreoli SP, Mallent CP, Bergstein JM: Role of glutathione in protecting endothelial cells against hydrogen peroxide oxidant injury. J Lab Clin Med 108:190-8(1986).
28. Garcia-Ruiz C, Colell A, Morales A, Kaplowitz M, Fernandez-Checa JC: Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: studies with isolated mitochondria and rat hepatocytes. Mol Pharmacol 48:825-34(1995).
29. Simoni J, Simoni G, Prien SD, Tran RM, Shires GT: The intracellular antioxidant defense system status after massive transfusion of free Hb-based blood substitutes. ASAJO J 41:3A(1995).
30. Feola M, Simoni J, Canizaro PC: Polyhemoglobin Stabilized by Purine Derivatives and Glutathione. Australian Patent No. 650 439 (1994).
31. Feola M, Simoni J, Canizaro PC: Blood Substitute. U.S. Patent No. 5 439 882 (1995).
32. Feola M, Simoni J, Canizaro PC: Polyhemoglobin Stabilized with Purine Derivatives and Glutathione. European Patent No. EP 0 507 870 (1996).
33. Simoni J, Simoni G, Feola M: Chromatographic analysis of biopolymers distribution in "polyhemoglobin", an intermolecularly crosslinked hemoglobin solution. Anal Chim Acta 279:73-88(1993).
34. Feola M, Simoni J, Canizaro PC: Quality control of hemoglobin solutions: I. the purity of hemoglobin before modification. Artif Organs 15:234-278(1991).
35. Simoni J, Simoni G, Feola M, Canizaro PC: Evaluation of anion-exchange liquid chromatography for purification of hemoglobin from peptides and other proteins. Anal Chim Acta 249:169-83(1991).
36. Winterbourn CC: Reactions of superoxide with hemoglobin, in Greenwald RA, (ed), Handbook of Methods for Oxygen Radicals Research, Boca Raton, FL, CRC Press, 1985, pp 137-41.
37. Simoni J, Simoni G, Lox CD, Prien SD, Shires GT; Hemoglobin interference with an enzyme-linked immunosorbent assay for detection of tumor necrosis factor-alpha.. Anal Chim Acta 313:1-14(1995).
38. Yamada T, Volkmer C, Grisham MB: The effect of sulfasalazine metabolites on hemoglobin-catalyzed lipid peroxidation. J Free Radic Biol Med 10:41-9(1991).
39. Yagi K: Assay for serum lipid peroxidase level and its clinical significance. In: Yagi H (ed): Lipid Peroxidase in Biology and Medicine, New York, Academic Press, 1982, pp 223-42.
40. Beutler D, Duron O, Kelly B: Improved method for the determination of blood glutathione. J Lab Clin Med 61:882-5(1963).
41. Singh S, Aggarwal BB: Activation of transcription factor NF-kappa B is suppressed by curcumin (Diferulolylmethane). J Biol Chem 270:24995-5000(1995).
42. Ramanujam P, Fogerty S, Heiser W, Jolly J: Fast gel electrophoresis to analyze DNA-protein interactions. BioTechniques 8:556-63(1990).
43. Simoni J, Simoni G, Lox CD, Prien SD, Tran R, Shires GT; Expression of adhesion molecules and von Willebrand factor in human coronary artery endothelial cells incubated with differently modified hemoglobin solutions. Artif Cells Blood Substit Immobil Biotechnol - in press.
44. 2+ in oxidant-induced NF-kappa B activation. FEBS Lett 385:58-62(1996).
45. Verma IM, Stevenson JK, Schwartz EM, Van Antwerp D, Miyamato S: Rel/NF-kappa B/I kappa B family; intimate tales of association and dissociation. Genes & Development 9:2723-35(1995).
46. Read MA, Whitley MZ, Williams AJ, Collins T: NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation. J Exp Med 179:503-12(1994).
47. Panl HL, Baeuerle PA: Oxygen and the control of gene expression. BioEssays 16:497-502(1994).
48. Anadalibi A, Liao F, Imes S, Fogelman AM, Lusis AJ: Oxidized lipoproteins influence gene expression by causing oxidative stress and activating the transcription factor NF-kappa B. Biochem Soc Trans 21:651-5(1993).
49. Henning B, Toborek M, Joshi-Barve S, Banger SW, Barve S, Mattson MP, McClain CJ: Linoleic acid activates nuclear transcription factor-kappa B (NF-kappa B) and induces NF-kappa B-dependent transcription in cultured endothelial cells. Am J Clin Nutr 63:322-8(1996).
50. Yoshida Y, Kashiba K, Niki E: Free radical mediated oxidation of lipids induced by hemoglobin in aqueous dispersions. Biochim Biophys Acta 1201:165-72(1994).
51. Simoni J, Simoni G, Garcia EL, Prien SD, Tran R, Feola M, Shires GT: Protective effect of selenium on hemoglobin mediated lipid peroxidation in vivo. Arty Cells Blood Substit Immobil Biotechnol 23:469-86(1995).
52. i elevation induced by erythrocyte components in endothelial cells. J Phramacol Exp Ther 277:1501-9(1996).
53. McFaul SJ, Bowman PD, Ibanez MG, Holt P: The effects of purified hemoglobin solutions on leukocytes and endothelial cells. Biomater Artif Cells Artif Organs 19:436(1991).
54. Simoni J, Simoni G, Newman G, Hartsell A, Feola M: A novel free Hb-based blood substitute. In vivo evaluation of its cardiovascular and renal effects. Artif Cells Blood Substit Immobil Biotechnol 24:427(1996).
55. Feola M, Simoni J, Angelillo R, Luhruma Z, Kabakele M, Manzobi M, Kaluila M: Clinical trial of a hemoglobin based blood substitute in patients with sickle cell anemia. Surg Gynecol Obstet 174:379-86(1992).
56. Simoni J, Simoni G, Newman G, Feola M: An improved blood substitute: In vivo evaluation of its hemodynamic effects. ASAIO Journal 42:M773-M782(1996).
57. Enger RL: Adenosine. The signal of life? Circulation 84:951-4(1991).
58. Havens J Jr, Obuako B, Thompson WJ, Downey J: Adenosine induced vasodilation: receptor characterization in pulmonary circulation. Am J Physiol 268:H1862-8(1995).
59. Daval JL, Nehling A, Nicolas F: Physiological and pharmacological properties of adenosine: therapeutic implications. Life Sci 49:1435-53(1991).
60. Yamagishi T, Yaginisawa T, Satoh K, Taira N: Relaxant mechanism of cyclic AMP-increasing agents in porcine coronary artery. Eur J Pharmacol 251:253-62(1994).
61. Silver PJ, Walus K, DiSalvo J: Adenosine-mediated relaxation and activation of cyclic AMP-dependent protein kinase in coronary arterial smooth muscle. J Pharmacol Exper Therap 228:342-7(1984).
62. Matsunaga T, Okumura K, Tsunoda R, Tayama S, Tabuchi K, Yasue H: Role of adenosine in regulation of coronary flow in dogs with inhibited synthesis of endothelium-derived nitric oxide. Am J Physiol 270: H427-34(1996).
63. Cronstein BN: Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 76:5-13(1994).
64. Maggirwar SB, Dhanraj DN, Somani SM, Ramkumar V: Adenosine acts as an endogenous activator of the cellular antioxidant defense system. Biochem Biophys Res Commun 201:508-15(1994).
65. Bouma MG, Stad RK, van der Wildenberg FAJM, Buurman WA: Differential regulatory effects of adenosine on cytokine release by activated human monocytes J Immunol 153:4159-68(1994).
66. Bouma MG, van der Wildenberg FAJM, Buurman WA: Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am J Physiol 270:C522-9(1996).
67. Adkins WK, Barnard JW, May S, Siebert AF, Haynes J, Taylor AE: Compounds that increase cAMP prevent ischemia-reperfusion pulmonary capilary injury. J Appl Physiol 72:492-7(1992).
68. Morandini R, Ghanem G, Portier-Lemarie A, Robaye B, Renaud A, Boeynaems JM: Action of cAMP on expression and release of adhesion molecules in human endothelial cells. Am J Physiol 270:H807-16(1996).
69. Ghersa P, van Huijsduijnen RH, Whelan J, Cambert Y, Pescini R, DeLamarter JF: Inhibition of E-selectin gene transcription through a cAMP-dependent protein kinase pathway. J Biol Chem 269:29129-37(1994).
70. 2+ by cAMP in vascular smooth muscle cells. Am J Physiol 258;C300-407(1990).
71. Jans DA: The regulation of protein transport to the nucleus by phosphorylation. Biochem J 311:705-16(1995).
72. Ramkumar V, Nie Z, Rybak LP, Maggirwar SB: Adenosine, antioxidant enzymes and cytoprotection. TiPS 16:283-5(1995).